The important uropathogen Proteus mirabilis encodes a record number of chaperone/usher-pathway adhesive fimbriae. Such fimbriae, which are used for adhesion to cell surfaces/tissues and for biofilm formation, are typically important virulence factors in bacterial pathogenesis. Here, the structures of the receptor-binding domains of the tip-located two-domain adhesins UcaD (1.5 Å resolution) and AtfE (1.58 Å resolution) from two P. mirabilis fimbriae (UCA/ NAF and ATF) are presented. The structures of UcaD and AtfE are both similar to the F17G type of tip-located fimbrial receptor-binding domains, and the structures are very similar despite having only limited sequence similarity. These structures represent an important step towards a molecular-level understanding of P. mirabilis fimbrial adhesins and their roles in the complex pathogenesis of urinary-tract infections.
Introduction
The urinary tract is a common target for bacterial infections. Urinary-tract infections (UTIs) are clinically categorized as uncomplicated or complicated. Uncomplicated UTIs occur in individuals that are otherwise healthy, with uropathogenic Escherichia coli (UPEC) being the main causative agent. Complicated UTIs affect patients with underlying difficulties such as indwelling catheters. Proteus mirabilis, a Gramnegative bacterium famous for its ability to swarm across agar surfaces, is a major player in causing catheter-associated UTIs (CAUTIs; Nielubowicz & Mobley, 2010) and complicated UTIs, including pyelonephritis, bacteraemia and urolithiasis (Rocha et al., 2007) . P. mirabilis utilizes a multitude of virulence factors, including urease, flagella and fimbriae, to establish and promote infection (Schaffer & Pearson, 2015) . Fimbriae are important virulence factors that are used for adhesion to cell surfaces/tissues and for biofilm formation (Schaffer & Pearson, 2015) . 17 fimbrial gene clusters (FGCs) encoding chaperone/usher (CU) fimbrial assembly machineries and associated fimbrial subunits have been identified in the genome sequence of P. mirabilis HI4320, a representative strain isolated from the urine of an elderly, long-term (!30 d) catheterized patient (Pearson et al., 2008) .
The CU pathway is commonly used by pathogenic Gramnegative bacteria to assemble Ig-like protein subunits ('pilins') into fimbriae (Geibel & Waksman, 2014; Zav'yalov et al., 2010) . In CU-mediated assembly, a periplasmic chaperone assists the folding of the incomplete immunoglobulin (Ig)-like pilin subunits and delivers them in a high-energy intermediate form (Zavialov et al., 2003) to the outer membrane usher, ISSN 2059-7983 # 2018 International Union of Crystallography where assembly and secretion to the cell surface takes place. CU fimbriae can be classified into two main groups. Fimbrial monoadhesins display a specialized two-domain adhesin (TDA) subunit at the tip of rod-like fimbriae. TDAs consist of an N-terminal domain (NTD) that is responsible for highaffinity binding to receptors (usually carbohydrates), joined through a short linker to a C-terminal pilin domain. Fimbrial polyadhesins are instead typically thin and flexible structures in which each fimbrial subunit can bind with weak affinity to one or two distinct host cell receptors. Multivalent binding of polyadhesins to their receptors provides tight binding via a considerable avidity effect. 14 of the 17 P. mirabilis FGCs encode a putative TDA and hence are likely to produce fimbrial monoadhesins if expressed. Two of the most studied of these are uroepithelial cell adhesin (UCA), also known as non-agglutinating fimbriae (NAF), and ambient temperature fimbriae (ATF).
UCA/NAF was first identified in 1986 (Wray et al., 1986) . The major adherence component was purified from the outer membrane fraction of a P. mirabilis preparation incubated with shed human uroepithelial cells. The isolated 17.5 kDa protein subunit was found to self-assemble as long and flexible rods of 4-6 nm in width. The uca FGC, which is homologous to the FGCs encoding the F17 family of fimbriae in UPEC (Cook et al., 1995) , encodes a major fimbrial subunit (UcaA), a chaperone (UcaB), an usher (UcaC), a TDA (UcaD) and a transcriptional regulator (UcaJ). An isogenic ucaA mutant was significantly impaired both in adherence to exfoliated human uroepithelial cells as well as in kidney colonization (Pellegrino et al., 2013) . UCA fimbriae were also found to contribute to fitness in a CAUTI mouse model (Armbruster et al., 2017) . Taken together, these findings suggest that UCA fimbriae are important for the establishment and progression of P. mirabilis UTI.
ATF are expressed from the atf FGC, which contains six genes, atfABCDEJ, encoding a major structural subunit (AtfA), a chaperone (AtfB), an usher (AtfC), a minor subunit (AtfD), a TDA (AtfE) and a transcriptional regulator (AtfJ) regulating ATF expression (Armbruster et al., 2018 ). An atfABC mutant was compared with the wild type in both independent-challenge and co-challenge experiments in an ascending UTI mouse model, and no obvious difference was found in bacterial counts in either bladder or kidneys 7 d postinoculation (Zunino et al., 2000) . This, together with the fact that ATF are maximally expressed in static culture at 23 C, suggests that rather than contributing to virulence, ATF play a role in environments external to a mammalian host (Zunino et al., 2000) . However, other studies have pointed to links between the production of ATF and MR/P fimbriae, which are a major contributor to bladder infection (Armbruster et al., 2018) , suggesting that ATF somehow also contribute to UTI. For instance, when ATF was discovered in 1994, AtfA was found to co-purify with MR/P fimbriae even when cells were grown in conditions favouring the expression of ATF (Massad et al., 1994 ). An isogenic mrpA mutant unable to express MR/P fimbriae was required in order to isolate ATF (Massad et al., 1994) . A later study compared bladder colonization in P. mirabilis mutant strains engineered with constitutive or no MR/P fimbrial production (locked ON or OFF; Jansen et al., 2004) . Strikingly, AtfA was found on the surface of bacteria colonizing mouse bladders 2 d after inoculation with the MR/P OFF strain, despite the unfavourable expression temperature. The MR/P OFF strain adhered to lamina propria underlying exfoliated uroepithelium, a pattern that was drastically different compared with MR/P ON and wild-type P. mirabilis, which both preferentially target intact uroepithelium. Also, the atfABC mutant was found to be the most affected among a collection of isogenic fimbrial mutant strains (including wild type, mrpA, pmfA and ucaA) in terms of biofilm formation and the ability to swarm across latex catheter segments (Scavone et al., 2016) . Therefore, the contribution of ATF to P. mirabilis pathogenesis might have been underestimated.
Here, we present the first two atomic structures of TDA receptor-binding domains from P. mirabilis fimbriae: UcaD and AtfE. Our work provides an important stepping stone towards a molecular-level understanding of P. mirabilis fimbrial adhesins and their roles in the complex pathogenesis of this important uropathogen.
Materials and methods

Construct design and cloning
Since pilin domains are very unstable and tend to aggregate in the absence of a chaperone, a convenient way to obtain material for structural and functional studies of TDAs is to express the receptor-binding NTDs by themselves (see, for example, Buts et al., 2003; Bouckaert et al., 2005) . Constructs encoding the NTDs of the AtfE and UcaD TDAs (AtfE ntd and UcaD ntd , respectively) were designed with the N-terminal signal peptides intact to ensure correct maturation following translocation to the periplasm. Initial putative domain borders were assigned based on multiple sequence alignment with pilin domains in combination with threading using Phyre2 (Kelley et al., 2015) . In order to optimize the constructs for protein expression, constructs with different numbers of residues included at the C-terminus were screened for soluble expression at the Protein Science Facility (PSF), Karolinska Institute, Stockholm, Sweden (http://ki.se/en/mbb/ protein-science-facility) using a ligation-free cloning methodology (Aslanidis & de Jong, 1990) . DNA encoding target constructs was PCR-amplified from P. mirabilis HI4320 genomic DNA. T4 DNA polymerase was used to produce complementary ssDNA overhangs on the PCR product and plasmid (pNIC-CH2). The expression plasmid introduces an additional alanine between the target DNA insertion site and the C-terminal His 6 tag encoded by the plasmid. Sequenceverified constructs were tested for small-scale expression using the E. coli BL21(DE3) R3 pRARE2 phage-resistant strain. The results of the PSF construct screening are shown in Table 1 . Protein from two PSF constructs for UcaD (psfUCAD-c002 and psfUCAD-c004) was used for crystallization. Since the AtfE PSF constructs provided only lowyield large-scale expression, the DNA encoding AtfE residues 1-210 and the C-terminal His 6 tag was PCR-amplified from research papers the corresponding PSF plasmid (psfATFE-c003; Table 1 ) and recloned into the pEXP5-CT/TOPO vector (Invitrogen, USA) for verification of the sequence. The verified plasmid was transformed into SHuffle Express T7 competent E. coli (K12 strain; New England BioLabs, USA) for expression, since the SHuffle strain provided higher expression levels in small-scale tests (10 ml LB culture) compared with BL21 strains. For simplicity, all constructs used for crystallization will be designated by the C-terminal end residue in the following.
Protein production and purification
For UcaD ntd , two constructs were used for structure determination. The UcaD 211 and UcaD 217 constructs were expressed in the E. coli BL21(DE3) R3 pRARE2 phageresistant strain by inoculating fresh lysogeny broth (LB) containing 50 mg ml À1 kanamycin with a 1% volume of overnight pre-culture. The cells were incubated at 37 C with shaking until the OD 600 reached 0.9. Isopropyl -d-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 mM. Induced expression was carried out at 18 C overnight.
For AtfE ntd , the AtfE 210 construct was expressed in SHuffle Express T7 competent E. coli cells (New England Biolabs, USA) by inoculating fresh LB medium containing 100 mg ml À1 ampicillin with a 1% volume of overnight pre-culture. The cells were incubated at 30 C (the recommended temperature for expression in SHuffle Express cells) with shaking until the OD 600 reached 1.2. The cells were then transferred to 4 C for 20 min to cool before IPTG was added to a final concentration of 0.5 mM and expression continued at 18 C overnight. The cells were harvested by centrifugation at 7500g at 4 C for 15 min. The harvested cells were homogenized in solubilization buffer [100 mM NaCl, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.5, 5% glycerol for UcaD ntd and 500 mM NaCl, 50 mM HEPES pH 7.8, 5 mM dithiothreitol (DTT) for AtfE ntd ], to which one tablet of cOmplete protease-inhibitor cocktail (Roche) and 10 mg ml À1 DNase (from bovine pancreas; Sigma-Aldrich) were added. The cell suspension was stirred at 4 C for 45 min before passage through a cell disruptor (Constant Systems, UK) twice at 207 MPa pressure to ensure adequate lysis. The cell lysate was centrifuged at 30 500g for 30 min at 4 C and the supernatant was collected.
Soluble fractions of both UcaD ntd and AtfE ntd were first purified by nickel-immobilized metal-affinity chromatography (Ni-IMAC). The imidazole concentration in the soluble fraction was adjusted to 5 and 20 mM, respectively, before binding to equilibrated Ni Sepharose 6 Fast Flow (GE Healthcare) resin. Impurities and target proteins were separated by adding increasing concentrations of imidazole to the buffer. Unbound protein and most impurities were washed away with 50 mM imidazole. UcaD ntd and AtfE ntd were eluted with 300 and 500 mM imidazole, respectively. UcaD ntd was further purified using a Superdex 75 16/60 column (GE Healthcare) equilibrated with the homogenization buffer.
Ni-IMAC-eluted AtfE ntd was buffer-exchanged into 2-morpholinoethanesulfonic acid (MES) buffer (50 mM MES pH 5.6, 10 mM -mercaptoethanol). A precipitate mainly consisting of impurities caused by the shift from pH 7.8 to 5.6 was removed by centrifugation at 6500g using a desktop centrifuge (Heraeus Multifuge 3SR with swing-out rotor 75006441). The protein was further purified using a HiTrap Heparin column (GE Healthcare), a two-mode chromatography agent with both affinity and cation-exchange capacity. AtfE ntd was eluted with a gradient of NaCl in 50 mM MES pH 5.6, 10 mM -mercaptoethanol. Typically, AtfE ntd eluted at 600 mM NaCl.
Crystallization
Crystallization was carried out by sitting-drop vapour diffusion using a Mosquito Crystal crystallization robot (TTP Labtech, England). A typical crystallization drop was prepared by mixing protein and reservoir solutions in a 1:1 ratio to give a final volume of 300 nl. Seed stocks were prepared by diluting a drop containing crystalline material 660-fold by volume with the corresponding reservoir. Seeding was performed on the dispensed plate by adding 30 nl seed stock to each 300 nl drop.
Diffraction-quality UcaD 211 crystals appeared overnight at 293 K after the seeding of drops with protein at 20 mg ml citrate pH 5.5, 20% PEG 3000 was used as a seed stock. The presence of cobalt was required for crystal formation. An iodine derivative of UcaD 211 for single anomalous dispersion (SAD) phasing was prepared by soaking the crystals in cryoprotectant containing NaI (0.005 M CoCl 2 , 0.1 M HEPES pH 7.5, 15% PEG 3350, 20% glycerol, 1 M NaI) for 45 min before flash-cooling in liquid nitrogen. UcaD 217 crystals for native data collection were obtained using protein at 16 mg ml À1 mixed with 2 M ammonium sulfate, 0.1 M bis-Tris pH 5.5. Diffraction-quality crystals appeared in a week at 293 K after seeding with seed stock from similar conditions. Crystals were cryoprotected with sucrose (by dropping a solid grain of sucrose into the crystallization drop) before flash-cooling with liquid nitrogen.
AtfE 210 crystals for native data collection were obtained using protein at 5 mg ml À1 in 0.8 M NaH 2 PO 4 , 0.8 M KH 2 PO 4 , 0.1 M HEPES pH 7.5. Diffraction-quality crystals appeared at 293 K 2-4 weeks after seeding with initial crystalline material obtained from similar conditions with 9 mg ml À1 AtfE 210 . The crystals were cryoprotected with 18% glycerol before flashcooling with liquid nitrogen. Crystals for iodine SAD phasing were grown in 0.7 M NaH 2 PO 4 , 0.7 M KH 2 PO 4 , 0.1 M sodium acetate pH 5.0 and were then soaked in 1 M NaI, 0.65 M NaH 2 PO 4 , 0.65 M KH 2 PO 4 , 0.1 M sodium acetate pH 5.0, 23% glycerol for 7 h prior to flash-cooling in liquid nitrogen.
Data collection and structure determination
Data collection was performed at 100 K at the European Synchrotron Radiation Facility (ESRF), Grenoble, France or at Diamond Light Source (DLS), UK. Diffraction data were processed using XDS (Kabsch, 2010) and scaled and merged using the CCP4 (Winn et al., 2011) program AIMLESS (Evans & Murshudov, 2013) . Experimental phasing and initial automatic model building was performed with PHENIX (Adams et al., 2010) using the phenix.autosol (Terwilliger et al., 2009) and phenix.autobuild (Terwilliger et al., 2008) et al., 2007) was used for molecular replacement. Refinement was carried out using phenix.refine (Afonine et al., 2012) . Torsional NCS restraints were applied during the refinement of structures with more than one protomer in the asymmetric unit (UcaD 217 and AtfE 210 ). All structures were modelled with isotropic temperature factors and TLS. Model building was performed using Coot (Emsley et al., 2010) . Structure validation was carried out using the tools available in phenix.refine (Afonine et al., 2012) and Coot (Emsley et al., 2010) . Resolution cutoffs were based on CC 1/2 (Karplus & Diederichs, 2012) and the completeness of the data. Native data-collection and refinement statistics are listed in Table 2 .
UcaD 211 crystallized in two crystal forms. Iodine SAD data for UcaD 211 were collected to 2.5 Å resolution on beamline I02 at DLS from a single crystal in space group P4 3 22 with two molecules in the asymmetric unit. Native UcaD 211 data were collected to 1.7 Å resolution on beamline ID23-2 at the ESRF from a single crystal in space group I4 1 22 with one molecule in the asymmetric unit. Native UcaD 217 data were collected to 1.5 Å resolution on beamline ID23-2 at the ESRF from a single crystal in space group P1 with two molecules in the asymmetric unit. iteratively remodelled and refined against the native UcaD 211 data. The resulting model was used as a search model to solve the UcaD 217 structure by molecular replacement.
AtfE 210 crystallized in one crystal form belonging to space group C2 with two molecules in the asymmetric unit. Native AtfE 210 data were collected to 1.6 Å resolution from a single crystal on beamline ID30A-3 at the ESRF. Iodine SAD data were collected to 2.5 Å resolution from four AtfE 210 derivative crystals on beamline ID23-1 at the ESRF. The initial SAD-phased model was iteratively remodelled and refined against the native data.
Other software
Structures were superimposed and structure-based sequence alignments were obtained using Chimera MatchMaker (Meng et al., 2006) . Multiple sequence alignment was performed with COBALT (Papadopoulos & Agarwala, 2007) and was visualized using ESPript 3.0 (Robert & Gouet, 2014) .
Graphical representations of protein structures were prepared using UCSF Chimera (Pettersen et al., 2004) .
Results and discussion
Both UcaD ntd and AtfE ntd were expressed with their native N-terminal signal peptides to ensure correct maturation following translocation to the periplasm. In all cases the first residue visible in the electron-density maps corresponded to the first residue after the predicted signal sequence. The start and end points of the crystallized proteins are listed in Table 1 .
Structure of UcaD ntd
Since no structural model with sufficient sequence identity was available in the Protein Data Bank (PDB) at the time, de novo SAD phasing using a sodium iodide derivative of UcaD 211 that diffracted to 2.5 Å resolution was used to obtain initial phases. Similar to other TDA receptor-binding domains, UcaD 211 adopts an Ig-like Greek-key fold. However, the Structure-based multiple sequence alignment of the NTDs of AtfE, F17aG, F17bG, F17cG, UclD and UcaD. Structures were superimposed with UcaD ntd to generate the alignment. Residues are numbered according to their position in the native sequences. Identical residues are highlighted with red shading and white text, and similar residues with a blue frame and red text. The top and bottom secondary-structure depictions refer to AtfE ntd and UcaD ntd respectively. Residues that form side-chain interactions with bound GlcNAc in F17aG, F17bG and F17cG are marked with red stars.
C-terminal His tag of UcaD 211 takes on part of the role of the final (G) strand in the fold ( Supplementary Fig. S1 ), suggesting that the domain border was trimmed too short and that the NTD in UcaD 211 is incomplete. Indeed, in the longer UcaD 217 construct the last six residues replace the His tag from the shorter construct to form the last -strand and complete the Ig-like fold (Fig. 1) . In the UcaD 211 structure, two cobalt-coordination sites were found in each asymmetric unit. One site is formed by His48 and two histidine residues from the His tag (His216 and His218). The second site is composed entirely of residues from the His tag: His213 and His215 in one protomer and His217 from the symmetryrelated protomer (Supplementary Fig. S1 ). This explains why cobalt ions were essential for the crystallization of the short construct.
The UcaD 211 and UcaD 217 structures are very similar, with r.m.s.d.s of 0.594 Å for 176 equivalent C atoms in UcaD 211 and chain A of UcaD 217 , and 0.763 Å for 179 equivalent C atoms in UcaD 211 and chain B of UcaD 217 . The largest differences are found in the C-terminal region, as expected, as well as in the six first residues (21-26) and in the BC loop, which interacts with the N-terminal region. These latter differences were initially attributed to differences in crystal packing (the N-terminal region is involved in crystal packing between the two protomers in the asymmetric unit in the UcaD 217 structure), but are likely to be caused by an unfortunate accidental Tyr-His mutation at position 25 in the UcaD 217 construct that was discovered in the final stages of refinement and was confirmed by resequencing of the construct. UcaD ntd forms an elongated (approximate dimensions 60 Â 35 Â 30 Å ) -sandwich with the N-and C-termini at opposite ends of the structure (Fig. 1a) . Based on the structures of other TDAs, the domain is expected to be oriented with its longest dimension along the direction of the fimbrial axis when incorporated into UCA fimbriae. Strands A1/2, G1/2, F1/2, C and D2 form one sheet of the sandwich, while strands B1/2, D1 and E form the second (referred to as the BED sheet below). The C-D and D-E loops (C 0 , C 00 ; D
0
, 2) form a flap covering the BED sheet of the -sandwich (Fig. 1) .
A DALI search (Holm & Sander, 1995) for structural homologues of UcaD ntd identified the NTDs of F17G and F17G-like fimbrial adhesins (F17cG and UclD, respectively) as the topscoring hits (Figs. 2a and 2b , Table 3 ). UcaD ntd shares 84% sequence identity with E. coli UclD ntd (Fig. 3) and hence might be expected to recognize a similar receptor. In contrast, the UcaD ntd sequence is only 15% identical to that of E. coli F17cG ntd .
An O-linked oligosaccharide has been suggested as a possible UclD receptor based on the observation that (Spaulding et al., 2017) . The region in UclD corresponding to the Nacetylglucosamine (GlcNAc)-binding pocket in F17cG (Buts et al., 2003; Fig. 4) was also suggested as a potential receptorbinding site in UclD (Spaulding et al., 2017) , despite none of the residues being conserved (Fig. 3) . The pocket found in this region in UcaD (and in UclD) is smaller and less charged than the F17cG pocket (Fig. 4) . The pocket is lined with residues (Gln63, Tyr123, Trp124, Asp140, Asn152, Thr155 and Ser157) that could potentially hydrogen-bond to, as well as form -stacking interactions with, a carbohydrate receptor. However, receptor-binding pockets are found in many different locations in fimbrial adhesins sharing the same overall Ig-like fold (De Greve et al., 2007; Moonens et al., 2012) , although in most cases they are located in the top half of the NTD. Hence, in the absence of firm knowledge about the identities of the UclD and UcaD receptor(s), and given the lack of any significant sequence similarity between UclD/ UcaD and F17cG, the prediction of a receptor-binding site based solely on a similar fold remains speculative. Purified UCA fimbriae have been shown to bind to asialo-GM1, asialo-GM2 and lactosyl ceramide glycolipids in vitro (Lee et al., 2000) . However, since anti-UCA antibodies (which would be expected to chiefly target the major subunit present in fimbriae in huge excess over the single TDA per fimbria) blocked binding to the glycolipids, the observed binding is likely to be mediated by the major subunit rather than by UcaD. Also, while asialo-GM1 is commonly found on the surface of neuronal and immune cells, its presence on the surface of bladder epithelial cells has not been shown, casting doubt on the relevance of this finding for UTI.
Structure of AtfE ntd
The AtfE 210 structure (Fig. 5) was solved by SAD phasing using a sodium iodide derivative. Despite the low sequence identity between AtfE ntd and UcaD ntd (18%; Fig. 3 ), the two structures are very similar (Fig. 2c) , with an r.m.s.d. of 1.175 Å for 98 matched C positions. As for UcaD ntd , the top DALI hits were UclD and F17cG (Table 3) . Both AtfE ntd and UcaD ntd have distinct extended C 0 C 00 insertions in the C-D loop compared with F17G TDAs (Figs. 1, 4 and 2c) . Both structures have an AGFC sheet made from split stands, similar to F17G TDAs. AtfE ntd has a disulfide bond between Cys67 and Cys75 linking the end of strand B to the first residue in strand C. A conserved disulfide bond is present in F17G NTDs, but this connects the beginning of strand C to the DE loop. In UcaD ntd there is no disulfide bond. In contrast to F17G TDAs, both AtfE ntd and UcaD ntd have a cis-proline (Pro143 in AtfE and Pro141 in UcaD) at a structurally equivalent position right after strand D2. In UcaD (and UclD), this proline comes right after the asparagine residue (Asp140) in the pocket corresponding to the GlcNAc-binding pocket in F17cG (Fig. 4) . Although cis-prolines often have specific structural and functional roles in proteins (Lorenzen et Three-dimensional crystal structure of AtfE ntd . (a) Cartoon representation of AtfE ntd . Secondary-structure elements are labelled A-G from the N-terminus to the C-terminus. -Strands forming a -sheet are in the same colour: -strands A1/2, G1/2, F1/2, C1 and D2 are coloured blue, B, E, D1 and C2 are coloured green and C 0 and C 00 are coloured grey. Coils are coloured pale yellow. (b) Topology diagram of AtfE ntd with the secondary-structure elements coloured in the same way as in (a). A disulfide bond is highlighted in yellow with dashed lines indicating the positions of the two cysteines that form a disulfide bond in AtfE ntd .
al., 2005), the significance of the UcaD/AtfE cis-proline is unclear.
Studies have suggested ATF-dependent binding to exfoliated bladder sections rather than to intact bladder surfaces (Jansen et al., 2004) . Such regions typically expose the barrier layer of sulfated glycosaminoglycans (sGAGs) just below the superficial layer of umbrella cells lining the urothelium. The most important sGAGs in the bladder are heparan sulfate (HS), chondroitin sulfate (CS) and dermatan sulfate (DS), with CS located on the superficial (luminal) layer of the urothelium, while HS is found deeper down in the urothelium, in the basal membrane (Janssen et al., 2013) . Interestingly, during affinity chromatography of AtfE 210 we noted binding of the protein to the heparin matrix at both pH 5.5 and 8.0, suggesting not only nonspecific charge-charge interactions but also specific binding. Examination of the electrostatic surface of AtfE ntd reveals a distinct positively charged ridge curving around the tip and extending approximately halfway down the domain (Fig. 6) . Two pockets are located within the borders of the ridge. It is tempting to speculate that this feature of AtfE might allow specific binding to sGAG structures such as, for example, HS, explaining the preferential binding to exfoliated bladder sections (Jansen et al., 2004) .
Conclusion
In summary, despite their divergent sequences, both AtfE ntd and UcaD ntd have similar structures. The structures, together with information from crystallization and protein-purification conditions, will provide the basis for future work on identifying receptors and the physiological functions of ATF and UCA.
Figure 6
Electrostatic surface potential of AtfE ntd . AtfE ntd is shown in the same orientation as UcaD ntd in Fig. 4 . A positively charged ridge curving around the tip and extending approximately halfway down the domain, and surrounding two pockets, is outlined in orange. The upper pocket is located in roughly the same area as the GlcNAc-binding pocket in F17cG (Fig. 4) .
